Red Herring: New biotech VC raises a record fund- April 24, 2000 “Versant Ventures, a new venture capital firm and fund, will not invest in Internet infrastructure, B2B, wireless, or any of the other hot spaces most VCs are flocking around. It will focus exclusively on medical devices, health care services, biotech/pharmaceuticals, and e-health.” - Versant is the counterpart to Redpoint, the exclusively IT VC firm spun out of Brentwood and IVP.